Skip to main content
SpringerLink
Log in

Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia

  • Review Article
  • Published:
Journal of Infection and Chemotherapy

Abstract

Mycoplasma pneumoniae is one of the main pathogens causing community-acquired respiratory tract infections in children and adults. Macrolide (ML) antibiotics are recognized generally as first-choice agents for M. pneumoniae infections, and these antibiotics were thought to have excellent effectiveness against M. pneumoniae for many years. In 2000, however, M. pneumoniae showing resistance to macrolides was isolated from clinical samples obtained from Japanese pediatric patients with community-acquired pneumonia (CAP). Since then, prevalence of ML-resistant M. pneumoniae isolates in pediatric patients has increased rapidly. In 2007, ML-resistant M. pneumoniae isolates were obtained from Japanese adults with CAP; numbers of such isolates also have gradually increased in Japan. Recently, similar antimicrobial resistance in M. pneumoniae has begun to emerge worldwide. In this review, we focus on changes of ML-resistant M. pneumoniae from year to year and consider resistance mechanisms as well as clinical features of patients with resistant M. pneumoniae infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Waites KB, Rikihisa Y, Taylor-Robinson D. Mycoplasma, Ureaplasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th edn. Washington: American Society for Microbiology; 2003. p. 972–90.

    Google Scholar 

  2. Hammerschlag MR. Mycoplasma pneumoniae infections. Curr Opin Infect Dis. 2001;14:181–6.

    Article  CAS  PubMed  Google Scholar 

  3. Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17:986–91.

    Article  CAS  PubMed  Google Scholar 

  4. Kashyap B, Kumar S, Sethi GR, Das BC, Saigal SR. Comparison of PCR, culture & serological tests for the diagnosis of Mycoplasma pneumoniae in community-acquired lower respiratory tract infections in children. Indian J Med Res. 2008;128:134–9.

    CAS  PubMed  Google Scholar 

  5. McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–37.

    Article  PubMed  Google Scholar 

  6. Morozumi M, Hasegawa K, Chiba N, Iwata S, Kawamura N, Kuroki H, et al. Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia. J Infect Chemother. 2004;10:274–9.

    Article  CAS  PubMed  Google Scholar 

  7. Nakayama E, Hasegawa K, Morozumi M, Kobayashi R, Chiba N, Iitsuka T, et al. Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture. J Infect Chemother. 2007;13:305–13.

    Article  CAS  PubMed  Google Scholar 

  8. Oguz F, Unuvar E, Aydin D, Yilmaz K, Sidal M. Frequency of Mycoplasma pneumoniae among atypical pneumonia of childhood. Turk J Pediatr. 2002;44:283–8.

    PubMed  Google Scholar 

  9. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med. 2008;102:1762–8.

    Article  PubMed  Google Scholar 

  10. Howard LS, Sillis M, Pasteur MC, Kamath AV, Harrison BD. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect. 2005;50:107–13.

    Article  CAS  PubMed  Google Scholar 

  11. Ishida T, Hashimoto T, Arita M, Ito I, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest. 1998;114:1588–93.

    Article  CAS  PubMed  Google Scholar 

  12. Martínez MA, Ruiz M, Zunino E, Luchsinger V, Avendaño LF. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57:1491–5.

    Article  PubMed  Google Scholar 

  13. Miyashita N, Ouchi K, Kawasaki K, Oda K, Kawai Y, Shimizu H, et al. Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit. 2008;14:387–91.

    Google Scholar 

  14. Porath A, Schlaeffer F, Lieberman D. The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect. 1997;34:41–8.

    Article  CAS  PubMed  Google Scholar 

  15. Takahashi T, Morozumi M, Chiba N, Asami R, Okada T, Murayama SY, et al. Prolonged Mycoplasma pneumoniae infection in an elderly patient with community-acquired pneumonia. J Infect Chemother. 2009;15:243–7.

    Article  PubMed  Google Scholar 

  16. Abele-Horn M, Busch U, Nitschko H, Jacobs E, Bax R, Pfaff F, et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol. 1998;36:548–51.

    CAS  PubMed  Google Scholar 

  17. Dorjgo-Zetsma JW, Verkooyen RP, Van Helden HP, Van der Nat H, Van den Bosch JM. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring Hospitalization. J Clin Microbiol. 2001;39:1184–6.

    Article  Google Scholar 

  18. Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM, Spanjaard L, Rijntjes J, van Waveren G, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol. 1999;37:14–7.

    CAS  PubMed  Google Scholar 

  19. Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods. 2000;41:45–51.

    Article  CAS  PubMed  Google Scholar 

  20. Ieven M, Ursi D, Van Bever H, Quint W, Niesters HG, Goossens H. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis. 1996;173:1445–52.

    CAS  PubMed  Google Scholar 

  21. Khanna M, Fan J, Pehler-Harrington K, Waters C, Douglass P, Stallock J, et al. The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart. J Clin Microbiol. 2005;43:565–71.

    Article  CAS  PubMed  Google Scholar 

  22. Morozumi M, Nakayama E, Iwata S, Aoki Y, Hasegawa K, Kobayashi R, et al. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol. 2006;44:1440–6.

    Article  CAS  PubMed  Google Scholar 

  23. Nadala D, Bossart W, Zucol F, Steiner F, Berger C, Lips U, et al. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis. 2001;39:15–9.

    Article  CAS  PubMed  Google Scholar 

  24. Otomo S, Yamamura J, Hayashi E, Nakamura T, Kakinuma H, Nakamoto Y, et al. Analysis of children with Chlamydophila (Chlamydia) pneumoniae and Mycoplasma pneumoniae respiratoryinfections by real-time PCR assay and serological tests. APMIS. 2008;116:477–83.

    Article  CAS  PubMed  Google Scholar 

  25. Pitcher D, Chalker VJ, Sheppard C, George RC, Harrison TG. Real-time detection of Mycoplasma pneumoniae in respiratory samples with an internal processing control. J Med Microbiol. 2006;55:149–55.

    Article  CAS  PubMed  Google Scholar 

  26. Templeton KE, Scheltinga SA, Graffelman AW, van Schie JM, Crielaard JW, Sillekens P, et al. Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol. 2003;41:4366–71.

    Article  CAS  PubMed  Google Scholar 

  27. Tjhie JH, van Kuppeveld FJ, Roosendaal R, Melchers WJ, Gordijn R, MacLaren DM, et al. Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections. J Clin Microbiol. 1994;32:11–6.

    CAS  PubMed  Google Scholar 

  28. Welti M, Jaton K, Altwegg M, Sahli R, Wenger A, Bille J. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis. 2003;45:85–95.

    Article  CAS  PubMed  Google Scholar 

  29. Felmingham D, Robbins MJ, Sanghrajka M, Leakey A, Ridgway GL. The in vitro activity of some 14-, 15- and 16-membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum. Drugs Exp Clin Res. 1991;17:91–9.

    CAS  PubMed  Google Scholar 

  30. Ishida K, Kaku M, Irifune K, Mizukane R, Takemura H, Yoshida R, et al. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1994;38:790–8.

    CAS  PubMed  Google Scholar 

  31. Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother. 2005;49:2302–6.

    Article  CAS  PubMed  Google Scholar 

  32. Rennie KA, Prasad ES, Wenman WM. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species. Diagn Microbiol Infect Dis. 1994;20:57–9.

    Article  CAS  PubMed  Google Scholar 

  33. Waites KB, Cassell GH, Canupp KC, Fernandes PB. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother. 1988;32:1500–2.

    CAS  PubMed  Google Scholar 

  34. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617–20.

    CAS  PubMed  Google Scholar 

  35. Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976–2006: emergence of macrolide-resistant strains. Jpn J Infect Dis. 2007;60:325–6.

    PubMed  Google Scholar 

  36. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52:348–50.

    Article  CAS  PubMed  Google Scholar 

  37. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009;28:693–6.

    Article  PubMed  Google Scholar 

  38. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother. 2009;53:2160–2.

    Article  CAS  PubMed  Google Scholar 

  39. Pereyre S, Charron A, Renaudin H, Bébéar C, Bébéar CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol. 2007;45:3534–9.

    Article  CAS  PubMed  Google Scholar 

  40. Xin D, Mi Z, Han X, Qin L, Li J, Wei T, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53:2158–9.

    Article  CAS  PubMed  Google Scholar 

  41. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008;52:3542–9.

    Article  CAS  PubMed  Google Scholar 

  42. Alexander ER, Foy HM, Kenny GE, Kronmal RA, McMahan R, Clarke ER, et al. Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N Engl J Med. 1966;275:131–6.

    Article  CAS  PubMed  Google Scholar 

  43. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect. 2008;56:326–31.

    Article  PubMed  Google Scholar 

  44. Feikin DR, Moroney JF, Talkington DF, Thacker WL, Code JE, Schwartz LA, et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin Infect Dis. 1999;29:1545–50.

    Article  CAS  PubMed  Google Scholar 

  45. Hauksdóttir GS, Jónsson T, Sigurdardóttir V, Löve A. Seroepidemiology of Mycoplasma pneumoniae infections in Iceland 1987–96. Scand J Infect Dis. 1998;30:177–80.

    Article  PubMed  Google Scholar 

  46. Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–1995. Eur J Epidemiol. 1997;13:581–6.

    Article  CAS  PubMed  Google Scholar 

  47. Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the “gold standard”. J Clin Microbiol. 2005;43:2277–85.

    Article  CAS  PubMed  Google Scholar 

  48. Narita M, Togashi T. Evaluation of a rapid IgM antibody detection kit for diagnosis of Mycoplasma pneumoniae infection during childhood. Kansenshogaku Zasshi. 2003;77:310–5.

    PubMed  Google Scholar 

  49. Daxboeck F, Kircher K, Krause R, Heinzl H, Wenisch C, Stanek G. Effect of age on antibody titer to Mycoplasma pneumoniae. Scand J Infect Dis. 2002;34:577–9.

    Article  PubMed  Google Scholar 

  50. Sillis M. The limitations of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections. J Med Microbiol. 1990;33:253–8.

    Article  CAS  PubMed  Google Scholar 

  51. Hansen LH, Mauvais P, Douthwaite S. The macrolide-ketolide antibiotic binding site is formed by structures in domain II and V of 23S ribosomal RNA. Mol Microbiol. 1999;31:623–31.

    Article  CAS  PubMed  Google Scholar 

  52. Poehlsgaard J, Douthwaite S. Macrolide antibiotic interaction and resistance on the bacterial ribosome. Curr Opin Investig Drugs. 2003;4:140–8.

    CAS  PubMed  Google Scholar 

  53. Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother. 2001;45:1–12.

    Article  CAS  PubMed  Google Scholar 

  54. Bryskier A, Agouridas C, Chantot JF. Ketolides: new semisynthetic 14-membered-ring macrolides. In: Zinner SH, Young LS, Acar JF, Neu HC, editors. Expanding indications for the new macrolides, azalides, and streptogramins. New York: Marcel Dekker Inc; 1997. p. 39–50.

    Google Scholar 

  55. Lucier TS, Heitzman K, Liu SK, Hu PC. Trasition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1995;39:2770–3.

    CAS  PubMed  Google Scholar 

  56. Pereyre S, Guyot C, Renaudin H, Charron A, Bébéar C, Bébéar CM. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48:460–5.

    Article  CAS  PubMed  Google Scholar 

  57. Ubukata K, Iwata S, Sunakawa K. In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Strptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J Infect Chemother. 2003;9:221–6.

    Article  CAS  PubMed  Google Scholar 

  58. Cattoir V, Merabet L, Legrand P, Soussy CJ, Leclercq R. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia. J Antimicrob Chemother. 2007;59:1010–2.

    Article  CAS  PubMed  Google Scholar 

  59. Reinert RR, Al-Lahham A. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22. Antimicrob Agents Chemother. 2005;49:3011–3.

    Article  CAS  PubMed  Google Scholar 

  60. Bébéar CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord. 2005;5:263–71.

    Article  PubMed  Google Scholar 

  61. Gruson D, Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM. In vitro development of resistance to six and four FQ in Mycoplasma pneumoniae and, respectively. Antimicrob Agents Chemother. 2005;49:1190–3.

    Article  CAS  PubMed  Google Scholar 

  62. Anokhina MM, Barta A, Nierhaus KH, Spiridonova VA, Kopylov AM. Mapping of the second tetracycline binding site on the ribosomal small subunit of E. coli. Nucleic Acids Res. 2004;32:2594–7.

    Article  CAS  PubMed  Google Scholar 

  63. Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell. 2000;103:1143–54.

    Article  CAS  PubMed  Google Scholar 

  64. Roberts MC, Koutsky LA, Holmes KK, LeBlanc DJ, Kenny GE. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother. 1985;28:141–3.

    CAS  PubMed  Google Scholar 

  65. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624–30.

    Article  CAS  PubMed  Google Scholar 

  66. Isozumi R, Yoshimine H, Morozumi M, Ubukata K, Ariyoshi K. Adult case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae. Respirology. 2009; 14(8):1206–8.

    Article  PubMed  Google Scholar 

  67. Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64:52–8.

    Article  CAS  PubMed  Google Scholar 

  68. Cousin-Allery A, Charron A, Barbeyrac BD, Fremy G, Jensen JS, Renaudin H, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124:103–11.

    Article  CAS  PubMed  Google Scholar 

  69. Numazaki K, Umetsu M, Adachi N. Mycoplasma pneumoniae infection and its genotypical characterization in children of Hokkaido, Japan. In Vivo. 2003;17:421–4.

    PubMed  Google Scholar 

  70. Schwartz SB, Thurman KA, Mitchell SL, Wolff BJ, Winchell JM. Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis. Clin Microbiol Infect. 2009;15:756–62.

    Article  CAS  PubMed  Google Scholar 

  71. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709–12.

    Article  CAS  PubMed  Google Scholar 

  72. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009; 15(6):380–3.

    Article  PubMed  Google Scholar 

  73. Denny FW, Clyde WA Jr, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis. 1971;123:74–92.

    CAS  PubMed  Google Scholar 

  74. Smith CB, Friedewald WT, Chanock RM. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med. 1967;276:1172–5.

    CAS  PubMed  Google Scholar 

  75. Lu YJ, Chen TH, Lin LH, Shen CM, Huang CH. Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience. J Microbiol Immunol Infect. 2008;41:307–10.

    CAS  PubMed  Google Scholar 

  76. John SD, Ramanathan J, Swischuk LE. Spectrum of clinical and radiographic findings in pediatric mycoplasma pneumonia. Radiographics. 2001;21:121–31.

    CAS  PubMed  Google Scholar 

  77. Wieslander A, Boyer MJ, Wroblewski H. Membrane protein structure. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology, pathogenesis. Washington: American Society for Microbiology; 1992. p. 93–112.

    Google Scholar 

  78. Chmura K, Bai X, Nakamura M, Kandasamy P, McGibney M, Kuronuma K, et al. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol. 2008;295:220–30.

    Article  CAS  Google Scholar 

  79. Broaders SA, Hooper WC, Phillips DJ, Talkington DF. Mycoplasma pneumoniae subtype-independent induction of proinflammatory cytokines in THP-1 cells. Microb Pathog. 2006;40:286–92.

    Article  CAS  PubMed  Google Scholar 

  80. Chaudhry R, Varshney AK, Malhotra P. Adhesion proteins of Mycoplasma pneumoniae. Front Biosci. 2007;12:690–9.

    Article  CAS  PubMed  Google Scholar 

  81. Layh-Schmitt G, Podtelejnikov A, Mann M. Proteins complexed to the P1 adhesin of Mycoplasma pneumoniae. Microbiology. 2000;146:741–7.

    CAS  PubMed  Google Scholar 

  82. Seto S, Miyata M. Attachment organelle formation represented by localization of cytadherence proteins and formation of the electron-dense core in wild-type and mutant strains of Mycoplasma pneumoniae. J Bacteriol. 2003;185:1082–91.

    Article  CAS  PubMed  Google Scholar 

  83. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.

    Article  CAS  PubMed  Google Scholar 

  84. Yang J, Hooper WC, Phillips DJ, Talkington DF. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun. 2002;70:3649–55.

    Article  CAS  PubMed  Google Scholar 

  85. Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev. 2004;15:157–68.

    Article  CAS  PubMed  Google Scholar 

  86. Narita M, Tanaka H, Yamada S, Abe S, Ariga T, Sakiyama Y. Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection. Clin Diagn Lab Immunol. 2001;8:1028–30.

    CAS  PubMed  Google Scholar 

  87. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol. 2000;7:909–14.

    CAS  PubMed  Google Scholar 

  88. Narita M, Tanaka H. Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae. Pediatr Pulmonol. 2007;42:397.

    Article  PubMed  Google Scholar 

  89. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, et al. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest. 2002;121:1493–7.

    Article  CAS  PubMed  Google Scholar 

  90. Abe S, Nakamura H, Inoue S, Takeda H, Saito H, Kato S, et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2000;22:51–60.

    CAS  PubMed  Google Scholar 

  91. Beović B, Bonac B, Kese D, Avsic-Zupanc T, Kreft S, Lesnicar G, et al. Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis. 2003;22:584–91.

    Article  PubMed  Google Scholar 

  92. Marrie TJ. Epidemiology of mild pneumonia. Semin Respir Infect. 1998;13:3–7.

    CAS  PubMed  Google Scholar 

  93. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol. 2003;36:267–78.

    Article  PubMed  Google Scholar 

  94. Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol. 2007;56:1625–9.

    Article  PubMed  Google Scholar 

  95. Kim DH, Lee KY, Kim MS, Youn YS, Hwang JY, Rhim JW, et al. Corticosteroid treatment in siblings affected with severe Mycoplasma pneumoniae pneumonia. Infect Chemother. 2009;41(3):190–5.

    Article  Google Scholar 

  96. Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis. 2008;198:1180–8.

    Article  CAS  PubMed  Google Scholar 

  97. Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis. 2000;31:1507–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Epidemiology for Infectious Agents, Graduate School of Infection Control Sciences, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minatoku, Tokyo, 108-8641, Japan

    Miyuki Morozumi & Kimiko Ubukata

  2. Laboratory of Infectious Diseases, Graduate School of Infection Control Sciences, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan

    Takashi Takahashi

Authors
  1. Miyuki Morozumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kimiko Ubukata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miyuki Morozumi.

About this article

Cite this article

Morozumi, M., Takahashi, T. & Ubukata, K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 16, 78–86 (2010). https://doi.org/10.1007/s10156-009-0021-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-009-0021-4

Keywords

Search

Navigation